
Opinion|Videos|April 30, 2025
Prevalence, Presentation, and the CHE Patient Journey
Author(s)Raj Chovatiya, MD, PhD
An expert discusses how chronic hand eczema (CHE) is a common condition affecting 1% to 5% of adults and is defined as hand eczema lasting at least 3 months or relapsing at least 2 times per year, distinct from atopic dermatitis.
Advertisement
Video content above is prompted by the following:
Overview of CHE
Panel Introduction
This summary features insights from Raj Chovatiya, MD, PhD, a dermatology specialist discussing CHE diagnosis, clinical presentation, and treatment approaches.
Key Themes:
- Definition and prevalence: CHE is defined as hand eczema lasting at least 3 months or relapsing at least 2 times per year, with point prevalence of 1% to 5% in adults and lifetime prevalence around 15%.
- Differentiation from atopic dermatitis: While atopic dermatitis can manifest on hands, CHE encompasses broader etiologies and clinical presentations.
- Disease burden: CHE presents significant functional limitations due to its impact on daily activities and occupational performance.
Notable Insights:
Dr Chovatiya emphasized that CHE is "common, burdensome, [and] highly symptomatic for patients, and something that we're probably missing the boat on in terms of really adding a name to it to get to the next step of treatment."
Advertisement
Latest CME
Advertisement
Advertisement
Trending on HCPLive
1
Emerge Phase 3: DT120 Shows Rapid, Durable Relief in MDD
2
A Real-World Case: Initiating Ritlecitinib After Years of Untreated Disease
3
Key Clinical Practice Pearls in Atopic Dermatitis, With Elaine Siegfried, MD
4
Skin of Color Savvy—A New Generation of Dermatology Leadership, With Umayr Shaikh, MPH
5





































































